DrugPatentWatch Database Preview
Drugs in Development Information for CS-3150
» See Plans and Pricing
What is the development status for investigational drug CS-3150?
CS-3150 is an investigational drug.
There have been 11 clinical trials for CS-3150.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2016.
The most common disease conditions in clinical trials are Hypertension, Renal Insufficiency, and Kidney Diseases. The leading clinical trial sponsors are Daiichi Sankyo Co., Ltd., Daiichi Sankyo Inc., and Daiichi Sankyo, Inc.
There are fourteen US patents protecting this investigational drug and one hundred and sixteen international patents.
Summary for CS-3150
| US Patents | 14 |
| International Patents | 116 |
| US Patent Applications | 18 |
| WIPO Patent Applications | 8 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2016-06-01) |
| Vendors | 9 |
Recent Clinical Trials for CS-3150
| Title | Sponsor | Phase |
|---|---|---|
| Study of CS-3150 in Patients With Primary Aldosteronism | Daiichi Sankyo Co., Ltd. | Phase 3 |
| Study of CS-3150 in Patients With Essential Hypertension | Daiichi Sankyo Co., Ltd. | Phase 3 |
| Study of CS-3150 Compared to Olmesartan in Patients With Essential Hypertension | Daiichi Sankyo Co., Ltd. | Phase 3 |
Clinical Trial Summary for CS-3150
Top disease conditions for CS-3150
Top clinical trial sponsors for CS-3150
US Patents for CS-3150
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| CS-3150 | Start Trial | Method for producing pyrrole derivative, and intermediate thereof | Daiichi Sankyo Company, Limited (Chuo-ku, JP) | Start Trial |
| CS-3150 | Start Trial | Solid composition of pyrrole carboxamide | Daiichi Sankyo Company, Limited (Chuo-ku, JP) | Start Trial |
| CS-3150 | Start Trial | Pharmaceutical for prophylaxis or treatment of hypertension | Daiichi Sankyo Company, Limited (Chuo-ku, JP) | Start Trial |
| CS-3150 | Start Trial | Method for producing pyrrole derivative, and intermediate thereof | Daiichi Sankyo Company, Limited (Chuo-ku, JP) | Start Trial |
| CS-3150 | Start Trial | Pyrrole derivatives as pharmaceutical agents | Exelixis, Inc. (South San Francisco, CA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for CS-3150
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| CS-3150 | Canada | 2922350 | 2033-08-27 | Start Trial |
| CS-3150 | China | 105473552 | 2033-08-27 | Start Trial |
| CS-3150 | European Patent Office | 3040330 | 2033-08-27 | Start Trial |
| CS-3150 | Spain | 2660988 | 2033-08-27 | Start Trial |
| CS-3150 | Hungary | E037007 | 2033-08-27 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
